TY - JOUR
T1 - Cancer immunotherapy
T2 - A treatment for the masses
AU - Blattman, Joseph N.
AU - Greenberg, Philip D.
PY - 2004/7/9
Y1 - 2004/7/9
N2 - Cancer immunotherapy attempts to harness the exquisite power and specificity of the immune system for the treatment of malignancy. Although cancer cells are less immunogenic than pathogens, the immune system is clearly capable of recognizing and eliminating tumor cells. However, tumors frequently interfere with the development and function of immune responses. Thus, the challenge for immunotherapy is to use advances in cellular and molecular immunology to develop strategies that effectively and safety augment antitumor responses.
AB - Cancer immunotherapy attempts to harness the exquisite power and specificity of the immune system for the treatment of malignancy. Although cancer cells are less immunogenic than pathogens, the immune system is clearly capable of recognizing and eliminating tumor cells. However, tumors frequently interfere with the development and function of immune responses. Thus, the challenge for immunotherapy is to use advances in cellular and molecular immunology to develop strategies that effectively and safety augment antitumor responses.
UR - http://www.scopus.com/inward/record.url?scp=3042844293&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3042844293&partnerID=8YFLogxK
U2 - 10.1126/science.1100369
DO - 10.1126/science.1100369
M3 - Review article
C2 - 15247469
AN - SCOPUS:3042844293
SN - 0036-8075
VL - 305
SP - 200
EP - 205
JO - Science
JF - Science
IS - 5681
ER -